ProShares Ultra Health Care Rating $46.83 -0.61 (-1.29%) As of 11:28 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock ProShares Ultra Health Care Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RXL Aggregate RatingModerate Buy 2.75Holdings in RXL have an aggregate rating of Moderate Buy based on 465 analyst ratings issued in the past year covering 19 companies (61.4% of the portfolio).RXL Aggregate Price Target$46.64High Prediction$46.64Average Prediction$46.64Low Prediction$46.64Holdings in RXL have an aggregate price target of $46.64 and a range of $46.64 to $46.64 covering 19 companies (61.4% of the portfolio).RXL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Health Care Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 RXL Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.14%LLYEli Lilly and Company$1,079.30+1.3%4.8153 of 5 stars2.87$1,227.00 13.7%30Trending NewsAnalyst Forecast8.08%JNJJohnson & Johnson$230.48-1.6%4.4485 of 5 stars2.74$253.04 9.8%27Trending News5.48%ABBVAbbVie$214.22-0.7%4.9253 of 5 stars2.88$253.43 18.3%25Positive News5.06%UNHUnitedHealth Group$378.48-2.6%4.2115 of 5 stars2.74$387.57 2.4%27Positive News4.37%MRKMerck & Co., Inc.$120.64-1.4%4.4617 of 5 stars2.68$128.18 6.2%192.63%AMGNAmgen$337.76-0.5%3.9243 of 5 stars2.48$355.19 5.2%31Positive NewsAnalyst Upgrade2.42%TMOThermo Fisher Scientific$446.60-0.4%4.8581 of 5 stars2.96$616.10 38.0%23Positive NewsDividend Announcement2.40%GILDGilead Sciences$135.24+0.7%4.6375 of 5 stars2.86$156.93 16.0%29Analyst Revision2.24%ISRGIntuitive Surgical$436.76-0.3%4.2039 of 5 stars2.67$579.33 32.6%27Positive NewsAnalyst Downgrade2.19%ABTAbbott Laboratories$86.57-1.0%4.9557 of 5 stars2.88$119.43 38.0%26Positive News2.12%PFEPfizer$25.83-0.3%3.9524 of 5 stars2.19$28.61 10.8%21Trending News1.74%BMYBristol Myers Squibb$58.35-1.9%4.7384 of 5 stars2.37$61.31 5.1%19Positive News1.71%CVSCVS Health$91.51-1.9%4.5219 of 5 stars2.85$98.88 8.1%26Analyst Forecast1.59%VRTXVertex Pharmaceuticals$437.05+0.6%4.6125 of 5 stars2.92$555.17 27.0%25Positive News1.57%SYKStryker$311.20-1.7%4.9737 of 5 stars2.73$395.48 27.1%221.56%DHRDanaher$172.05+0.0%4.7607 of 5 stars2.86$238.65 38.7%22Positive News1.45%MDTMedtronic$77.74-1.1%4.9495 of 5 stars2.58$106.45 36.9%261.35%MCKMcKesson$754.86-1.5%4.9378 of 5 stars2.82$968.87 28.4%17Positive News1.25%ELVElevance Health$387.24-1.9%4.3849 of 5 stars2.61$403.11 4.1%23Positive NewsAnalyst Forecast This page (NYSEARCA:RXL) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredNo. You’re not imagining it…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredNew Warning From Our CEOMarketWise CEO Dr. David 'Doc' Eifrig, a former Goldman Sachs derivatives trader, has released an urgent brief...Stansberry Research | SponsoredI was right about SpaceX. Now here's the part that mattersGoldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Health Care Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Health Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
